Skip to Content

Bionik Laboratories Corp BNKL

Morningstar Rating
$0.00 −0.10 (100.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BNKL is trading at a 47% discount.
Price
$0.10
Fair Value
$7.86
Uncertainty
Extreme
1-Star Price
$8.72
5-Star Price
$1.16
Economic Moat
Gtkx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BNKL is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.10
Day Range
$0.000.00
52-Week Range
$0.002.90
Bid/Ask
$0.01 / $0.15
Market Cap
$12.48
Volume/Avg
1,000 / 2,781

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.38
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Bionik Laboratories Corp is a healthcare company focused on improving the quality of life of millions of people with neurological or mobility impairments by combining artificial intelligence and innovative robotics technology to help individuals from hospital to home regain mobility, enhance autonomy, and regain self-esteem. The company uses artificial intelligence and machine learning technologies to make rehabilitation methods and processes smarter and more intuitive to deliver a greater recovery for patients with neurological or mobility impairments. Its products The InMotion ARM, and InMotion ARM/HAND are robotic therapies for the upper limbs.
Sector
Healthcare
Industry
Medical Care Facilities
Stock Style Box
Small Core
Total Number of Employees
12

Valuation

Metric
BNKL
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
0.38
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
BNKL
Quick Ratio
0.38
Current Ratio
1.20
Interest Coverage
−45.16
Quick Ratio
BNKL

Profitability

Metric
BNKL
Return on Assets (Normalized)
−116.83%
Return on Equity (Normalized)
−792.11%
Return on Invested Capital (Normalized)
−256.46%
Return on Assets
BNKL
See how this stock stacks up to its competitors with Morningstar Investor

Medical Care Facilities Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
HCA
HCA Healthcare IncSzrddlrcwFmjfhcf$83.1 Bil
FSNUY
Fresenius SE & Co KGaA ADRXjtrvq$16.6 Bil
FSNUF
Fresenius SE & Co KGaARvytbjg$16.4 Bil
BDUUY
Bangkok Dusit Medical Services PCL ADRDdmdh$12.3 Bil
FMCQF
Fresenius Medical Care AGVwgjkv$11.9 Bil
FMS
Fresenius Medical Care AG ADRMgyqrCqgds$11.9 Bil
DVA
DaVita IncMcttrkztWsrkvp$11.6 Bil
UHS
Universal Health Services Inc Class BSbpvwq$11.1 Bil
THC
Tenet Healthcare CorpLqxcpzkkRfjv$9.7 Bil
AMN
AMN Healthcare Services IncKldmrlfCjnfwn$2.2 Bil

Sponsor Center